13F Filings History of Redmile Group, LLC

Latest 13F report
Q4 2025 - 17 Feb 2026
Value $
$1,357,911,173
Signature - Title
Joshua Garcia - Authorized Signatory
Location
San Francisco, CA
Summary
This page shows a list of all the recent 13F filings made by Redmile Group, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Redmile Group, LLC reported 34 stock holdings with total value $1,357,911,173 as of Q4 2025. Top holdings included SRRK, KRYS, NRIX, STOK, and IMNM.

Notify me when Redmile Group, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 34 $1,357,911,173 +$222,004,174 -$259,522,732 -$37,518,558 SRRK, KRYS, NRIX, STOK, IMNM 13F-HR 17 Feb 2026, 16:15
Q3 2025 40 $1,027,815,748 +$21,508,541 -$140,464,636 -$118,956,095 SRRK, KRYS, STOK, ZYME, ADCT 13F-HR 14 Nov 2025, 16:18
Q2 2025 48 $939,575,089 +$20,570,488 -$225,290,947 -$204,720,459 SRRK, KRYS, ZYME, STOK, IMNM 13F-HR 14 Aug 2025, 16:15
Q1 2025 56 $1,057,997,904 +$48,457,026 -$92,105,909 -$43,648,883 SRRK, KRYS, FOLD, ZYME, NRIX 13F-HR 15 May 2025, 17:00
Q4 2024 62 $1,434,861,498 +$57,028,802 -$205,274,928 -$148,246,126 SRRK, KRYS, NRIX, ZYME, FOLD 13F-HR 14 Feb 2025, 16:21
Q3 2024 63 $1,697,433,149 +$43,806,400 -$154,727,327 -$110,920,927 KRYS, NRIX, FOLD, IMNM, KYMR 13F-HR 14 Nov 2024, 16:15
Q2 2024 63 $1,653,982,972 +$47,048,389 -$529,080,896 -$482,032,507 KRYS, FOLD, NRIX, STOK, IMNM 13F-HR 14 Aug 2024, 16:16
Q1 2024 77 $2,724,553,242 +$468,170,022 -$882,420,336 -$414,250,314 KRYS, FOLD, IMNM, SRRK, FATE 13F-HR 15 May 2024, 16:50
Q4 2023 70 $2,795,946,341 +$464,790,729 -$319,459,062 +$145,331,667 IMGN, KRYS, FOLD, SRRK, RYZB 13F-HR 14 Feb 2024, 16:16
Q3 2023 68 $2,101,757,147 +$137,370,986 -$372,169,364 -$234,798,378 IMGN, KRYS, FOLD, AKRO, AUGX 13F-HR 14 Nov 2023, 16:15
Q2 2023 72 $2,605,471,616 +$486,907,795 -$443,367,244 +$43,540,551 IMGN, KRYS, FOLD, REPL, AKRO 13F-HR 14 Aug 2023, 16:15
Q1 2023 76 $2,304,694,420 +$383,434,767 -$272,636,360 +$110,798,407 FOLD, KRYS, ISEE, DCPH, AKRO 13F-HR 15 May 2023, 16:15
Q4 2022 69 $2,444,691,159 +$290,235,766 -$326,762,499 -$36,526,733 FOLD, KRYS, AKRO, REPL, FATE 13F-HR 14 Feb 2023, 16:18
Q3 2022 70 $2,578,101,000 +$313,407,547 -$484,740,916 -$171,333,369 FATE, FOLD, KRYS, ARGX, PLRX 13F-HR 14 Nov 2022, 16:03
Q2 2022 71 $2,618,868,000 +$274,528,899 -$149,491,073 +$125,037,826 FATE, FOLD, SGEN, ARGX, KRYS 13F-HR 15 Aug 2022, 17:22
Q1 2022 70 $3,192,748,000 +$178,781,181 -$180,032,134 -$1,250,953 FATE, FOLD, ARGX, LIVN, KRYS 13F-HR 16 May 2022, 16:13
Q4 2021 71 $4,398,640,000 +$448,796,227 -$734,531,488 -$285,735,261 FATE, FOLD, SNCE, ARGX, LIVN 13F-HR 14 Feb 2022, 17:07
Q3 2021 75 $5,733,591,000 +$516,194,914 -$714,100,753 -$197,905,839 FATE, ALLK, IGMS, ARGX, ADCT 13F-HR 15 Nov 2021, 16:16
Q2 2021 86 $6,757,873,000 +$476,038,134 -$812,163,331 -$336,125,197 FATE, IGMS, BEAM, ARGX, FOLD 13F-HR 16 Aug 2021, 17:00
Q1 2021 86 $7,099,728,000 +$1,134,871,638 -$1,396,027,774 -$261,156,136 FATE, ALLK, IGMS, ARGX, FOLD 13F-HR 17 May 2021, 16:05
Q4 2020 87 $8,246,791,000 +$1,611,254,688 -$739,276,030 +$871,978,658 FATE, FOLD, ALLK, BEAM, IGMS 13F-HR 16 Feb 2021, 16:06
Q3 2020 81 $5,447,026,000 +$1,149,527,813 -$1,066,163,520 +$83,364,293 FATE, FOLD, IMMU, ARGX, IGMS 13F-HR 16 Nov 2020, 16:09
Q2 2020 80 $5,416,834,000 +$1,478,958,239 -$723,537,308 +$755,420,931 FATE, FOLD, DCPH, ADCT, ARGX 13F-HR 14 Aug 2020, 16:16
Q1 2020 69 $3,566,983,000 +$673,976,931 -$673,746,635 +$230,296 FATE, FOLD, DCPH, BIIB, IGMS 13F-HR 15 May 2020, 16:04
Q4 2019 64 $4,180,807,000 +$1,114,142,270 -$854,190,481 +$259,951,789 DCPH, ALLK, FOLD, FATE, EPZM 13F-HR 14 Feb 2020, 16:10
Q3 2019 74 $2,988,202,000 +$709,059,437 -$838,013,543 -$128,954,106 ALLK, FOLD, FATE, DCPH, ALDR 13F-HR 14 Nov 2019, 16:11
Q2 2019 80 $3,525,347,000 +$596,115,406 -$639,382,285 -$43,266,879 ARRY, FOLD, FATE, ARGX, QURE 13F-HR 14 Aug 2019, 16:04
Q1 2019 82 $3,417,745,000 +$661,811,532 -$299,723,004 +$362,088,528 ARRY, FOLD, FATE, ATRA, ARGX Restatement 17 May 2019, 20:56
Q4 2018 78 $2,486,494,000 +$373,077,638 -$589,757,553 -$216,679,915 ARRY, ATRA, FATE, XNCR, WVE Restatement 16 May 2019, 15:34
Q3 2018 83 $3,250,425,000 +$698,555,479 -$489,590,361 +$208,965,118 ARRY, ATRA, FATE, RGNX, XNCR Restatement 16 May 2019, 15:34
Q2 2018 81 $2,943,811,000 +$704,699,695 -$592,940,669 +$111,759,026 ARRY, FOLD, ATRA, IMGN, XNCR 13F-HR 14 Aug 2018, 16:32
Q1 2018 64 $2,589,659,000 +$592,066,336 -$522,470,069 +$69,596,267 ARRY, ATRA, FOLD, IMGN, XNCR 13F-HR 15 May 2018, 16:30
Q4 2017 1 $6,604,000 $0 $0 $0 LIFE New Holdings 08 Mar 2018, 16:01
Q4 2017 70 $2,300,189,000 +$678,305,030 -$390,699,405 +$287,605,625 ARRY, FOLD, PBYI, CLVSQ, WVE 13F-HR 14 Feb 2018, 17:03
Q3 2017 65 $2,027,191,000 +$627,926,854 -$466,727,514 +$161,199,340 ARRY, FOLD, PBYI, SGEN, CLVSQ 13F-HR 14 Nov 2017, 16:23
Q2 2017 62 $1,619,615,000 +$373,969,722 -$424,078,425 -$50,108,703 ARRY, FOLD, PEN, PBYI, CLVSQ 13F-HR 14 Aug 2017, 17:39
Q1 2017 60 $1,540,736,000 +$489,457,893 -$303,271,349 +$186,186,544 ARRY, PEN, FOLD, PBYI, CLVSQ 13F-HR 15 May 2017, 16:41
Q4 2016 50 $1,160,076,000 +$246,477,456 -$231,001,622 +$15,475,834 ARRY, SGEN, CLVSQ, PEN, FOLD 13F-HR 14 Feb 2017, 16:40
Q3 2016 51 $1,257,292,000 +$383,299,430 -$414,983,168 -$31,683,738 ARRY, SGEN, FOLD, CLVSQ, GWPH 13F-HR 14 Nov 2016, 18:26
Q2 2016 54 $1,046,928,000 +$259,694,199 -$254,506,568 +$5,187,631 ARRY, FOLD, MDVN, SGEN, ATRA 13F-HR 15 Aug 2016, 18:47
Q1 2016 46 $965,552,000 +$246,400,057 -$341,859,175 -$95,459,118 FOLD, MDVN, CLVSQ, PEN, ARRY 13F-HR 16 May 2016, 17:22
Q4 2015 56 $1,295,666,000 +$364,890,903 -$380,189,990 -$15,299,087 FOLD, MDVN, PEN, ARRY, ITCI 13F-HR 16 Feb 2016, 16:53
Q3 2015 58 $1,319,989,000 +$735,472,038 -$521,152,312 +$214,319,726 FOLD, CLVSQ, ARRY, MDVN, INCY Restatement 17 Nov 2015, 15:23
Q2 2015 55 $1,220,168,000 +$393,875,998 -$366,371,697 +$27,504,301 ARRY, FOLD, VRX, CLVSQ, TEVA 13F-HR 14 Aug 2015, 16:27
Q1 2015 54 $1,113,749,000 +$434,668,244 -$346,345,076 +$88,323,168 ARRY, CLVSQ, FOLD, VRX, TEVA 13F-HR 15 May 2015, 19:11
Q4 2014 54 $918,447,000 +$209,894,019 -$257,161,997 -$47,267,978 FOLD, ARRY, VRX, CMRX, RAD 13F-HR 17 Feb 2015, 19:28
Q3 2014 52 $812,009,000 +$313,788,605 -$344,698,736 -$30,910,131 VRX, B108PS, CLVSQ, CELG, FOLD 13F-HR 14 Nov 2014, 16:29
Q2 2014 47 $822,448,000 +$333,988,028 -$328,158,239 +$5,829,789 B108PS, MDT, ARRY, UHS, HCA 13F-HR 14 Aug 2014, 18:52
Q1 2014 55 $837,581,000 +$362,855,695 -$443,276,323 -$80,420,628 B108PS, HCA, A, VRX, CLVSQ Restatement 19 Aug 2014, 14:09
Q4 2013 55 $796,219,000 $0 $0 $0 GILD, CLVSQ, ZBH, CELG, AZN 13F-HR 14 Feb 2014, 17:16